Perú | info:eu-repo/semantics/article
dc.date.accessioned2022-01-18T19:26:45Z
dc.date.available2022-01-18T19:26:45Z
dc.date.created2022-01-18T19:26:45Z
dc.date.issued2012
dc.identifierhttps://hdl.handle.net/20.500.12866/10837
dc.identifierhttps://doi.org/10.1016/j.actatropica.2011.06.018
dc.description.abstractLatin America contributes 1-1.2 million clinical malaria cases to the global malaria burden of about 300 million per year. In 21 malaria endemic countries, the population at risk in this region represents less than 10% of the total population exposed worldwide. Factors such as rapid deforestation, inadequate agricultural practices, climate change, political instability, and both increasing parasite drug resistance and vector resistance to insecticides contribute to malaria transmission. Recently, several malaria endemic countries have experienced a significant reduction in numbers of malaria cases. This is most likely due to actions taken by National Malaria Control Programs (NMCP) with the support from international funding agencies. We describe here the research strategies and activities to be undertaken by the Centro Latino Americano de Investigación en Malaria (CLAIM), a new research center established for the non-Amazonian region of Latin America by the National Institute of Allergy and Infectious Diseases (NIAID). Throughout a network of countries in the region, initially including Colombia, Guatemala, Panama, and Peru, CLAIM will address major gaps in our understanding of changing malaria epidemiology, vector biology and control, and clinical malaria mainly due to Plasmodium vivax. In close partnership with NMCPs, CLAIM seeks to conduct research on how and why malaria is decreasing in many countries of the region as a basis for developing and implementing new strategies that will accelerate malaria elimination.
dc.languageeng
dc.publisherElsevier
dc.relationActa Tropica
dc.relation1873-6254
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.rightsinfo:eu-repo/semantics/restrictedAccess
dc.subjectHumans
dc.subjectPeru
dc.subjectarticle
dc.subjectAnimals
dc.subjectnonhuman
dc.subjectpathogen
dc.subjectpolymerase chain reaction
dc.subjectdiagnostic test
dc.subjectdisease control
dc.subjectepidemiology
dc.subjectMalaria
dc.subjectmalaria control
dc.subjectmedical research
dc.subjectparasite transmission
dc.subjectPlasmodium
dc.subjectPlasmodium vivax
dc.subjectpopulation research
dc.subjectvector control
dc.subject|Socioeconomic Factors
dc.subjectagriculture
dc.subjectAnopheles (genus)
dc.subjectAnopheles mosquitoes
dc.subjectantimalarial drug resistance
dc.subjectColombia
dc.subjectdeforestation
dc.subjectDelivery of Health Care
dc.subjectDisease Eradication
dc.subjectdrug indication
dc.subjectDrug Resistance
dc.subjectglucose 6 phosphate dehydrogenase deficiency
dc.subjectGuatemala [Central America]
dc.subjectImidazoles
dc.subjectInsect Vectors
dc.subjectinsecticide resistance
dc.subjectInternational Cooperation
dc.subjectLatin America
dc.subjectMalaria elimination
dc.subjectMalaria pathogenesis
dc.subjectMalaria Vaccines
dc.subjectNational Health Programs
dc.subjectNiacin
dc.subjectNon-Amazon regions
dc.subjectPanama [Central America]
dc.subjectpolitical system
dc.subjectrapid diagnostic test
dc.subjectSouth and Central America
dc.titleProspects for malaria elimination in non-Amazonian regions of Latin America
dc.typeinfo:eu-repo/semantics/article


Este ítem pertenece a la siguiente institución